Antiretroviral Drugs Market Key Challenges 2022-28

1. Antiretroviral Drugs Market, 2022 - 2028 1

2. Market Overview: The global antiretroviral drugs market size was valued at USD 62.9 billion in 2021, growing at a CAGR of 3.6% during the forecast period 2022-28. The antiretroviral drugs market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the antiretroviral drugs market analysis from 2022 to 2028 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

3. Market Segments: The global antiretroviral drugs market has been fragmented based on: 1) By Drug Class: Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrate Inhibitors, Fusion Inhibitors, Chemokine Receptor Inhibitors, Others. 2) By Administration: Oral, Parenteral. 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others. 4) By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report 3

4. Key Players: Some of the major key players in the antiretroviral drugs market are: F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc AbbVie Merck & Co., Inc. Johnson & Johnson Services, Inc. Request Sample Report 4

5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5